Real Chemistry Acquires conversationHEALTH
April 5, 2022
Real Chemistry, a San Francisco-based health innovation company, has acquired conversationHEALTH, a HIPAA-compliant conversational AI SaaS platform for the health care and life sciences industry. The acquisition expands Real Chemistry's Data and Artificial Intelligence Solutions capabilities by adding conversational AI, medically-trained NLU and intelligent agents for scientific communications, medical affairs, clinical trials and commercial operations.
- Buyers
- Real Chemistry
- Targets
- conversationHEALTH
- Platforms
- Real Chemistry
- Industry
- Healthcare Services
- Location
- Ontario, Canada
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Real Chemistry Acquires Avant Healthcare
February 6, 2024
Healthcare Services
Real Chemistry has acquired Avant Healthcare, a Carmel, Indiana-based medical communications firm, to expand its medical education, medical affairs and HCP communications capabilities. The acquisition, which closed Feb. 1, 2024 for undisclosed terms, more than doubles Real Chemistry’s medical team and enhances its scientific, data-driven medical communications offering for life sciences clients.
-
Real Chemistry Acquires TI Health and Integrates It into Swoop
March 1, 2023
Data & Analytics
Real Chemistry has acquired TI Health, a data-driven HCP engagement and predictive analytics company, and will integrate TI Health into Swoop to create a unified HCP and DTC system of engagement for healthcare marketers. TI Health, previously a portfolio company of Capital Dynamics, Star Mountain Capital, and Halyard Capital, will bring its Affiniti platform and HCP targeting capabilities to Swoop’s privacy-safe patient audiences to enable coordinated omnichannel campaigns.
-
Real Chemistry Acquires Greater Than One
July 22, 2025
Marketing & Advertising
Real Chemistry has acquired Greater Than One, an award-winning healthcare-first media, technology and omnichannel strategy agency. The deal brings Greater Than One's proprietary media planning and engagement tools into Real Chemistry's AI-driven healthcare marketing platform to expand capability and performance for pharma and biotech clients; terms were not disclosed.
-
Real Chemistry Acquires Spring & Bond
October 15, 2025
Marketing & Advertising
Real Chemistry has acquired Spring & Bond, a New York–based digital media agency focused on omnichannel, data-driven media for the healthcare sector. The deal strengthens Real Chemistry's media and omnichannel capabilities; Spring & Bond's founder Elizabeth Beringer will continue to lead the team reporting to Kevin Johnson.
-
Amplity Health Acquires RealHealthData
January 1, 2019
Data & Analytics
Amplity Health has acquired RealHealthData and integrated its real-world data analytics capabilities into a new practice called Amplity Insights. The acquisition adds unstructured clinical and provider encounter data and analytic tooling to Amplity’s healthcare commercialization services to enhance client insights and decision-making.
-
Amwell Acquires SilverCloud Health and Conversa Health
July 28, 2021
Healthcare Services
Amwell announced definitive agreements to acquire digital mental health platform SilverCloud Health and virtual care automation firm Conversa Health to expand its longitudinal and behavioral care capabilities. The combined purchase price is approximately $320 million (mix of stock and cash); the acquisitions are expected to close in Q3 2021 and will broaden Amwell’s reach across health systems, plans and employers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.